a public good project by the
Synthesis
Company
of California

© 2026

Thanmai Posina | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Thanmai Posina

Moffitt Cancer Center(US)

Research Areas

Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Cancer Research and Treatments

Most-Cited Works

→ Abstract CT052: A phase IB study of mRNA-based active cancer vaccine, BI1361849, combined with durvalumab and tremelimumab immunotherapy in patients with non-small cell lung cancer (NSCLC)(2024)5 cited